We detected the expression of KK-LC-1 in the tumor tissues of liver cancer patients by immunohistochemistry (IHC) and found that 34.4% (45/131) of them showed a high expression of KK-LC-1 (Fig. 1a, b). Here, CT83 is linked to liver cancer.